dapagliflozin
astrazeneca
[]
 deliver trial 6263 pts with lvef&gt;= 40% 2.3 y median f/u 1mary endpoint cvd + hfh 18% in dapa group results were similar &lt;60% and &gt;60%
#esccongress 
HF Specialists of Tomorrow (Türkiye)